Day 1 May 17, Thursday

8:30-9:00 Registration & Refresh Coffee

9:00-9:10 Welcome Remark

9:10-9:50 Mr. James J. HO, MD, PhD, DABCC，Professor, Director of Peking Union Medical College & Chinese Academy of Medical Sciences, Center for Clinical Laboratory Development; Chairman and CEO of Beijing Lawke Health Laboratory Co. Ltd.

Topic: Who Sets the Rules -- Chinese CRO Central Lab Going International

9:50-10:30 Mr. Charlie XU, MD, PhD, VP of Clinical Services at Frontage Lab China

Topic: Clinical CROs in China -- Prospective and Globalization

10:30-10:50 Coffee Break + Exhibition Visit

10:50-11:25 Mr. Zhenping WU, PhD, M.B.A. Senior Vice President, Pharmaceutical Sciences at HMP

Topic: Selection Criteria for Contract Organizations -- An Insider's View

11:25-12:00 Ms. Lin HE, PhD, Senior Director of Strategic Development Department of Shanghai Pharmaceutical Clinical Research Center

Topic: China and Global CRO Industrial Development Trends

12:00-13:30 Luncheon

13:30-14:10 Mr. Dan ZHANG, Chairman & CEO of Fountain Medical Development Ltd.

Topic: Managing Safety Issues in Clinical Development in China: The Role of CRO

14:10-14:50 Mr. Tony SONG, Manager of Life Science Market in 3M Purification division

Topic: Filtration Technologies in Pharmaceutical R&D Phase and 3M Validation Service

14:50-15:00 Q & A – All conference participants self-introduction

15:00-15:20 3M Release of Certification Laboratory

15:20-15:40 Coffee Break + Exhibition Visit

15:40-16:20 Ms. Weijun SHA, BD Director & Project Director of TigerMed

Topic: Creating New Valuable Working Model through Strategic Partnership with Clients

16:20-17:00 Panel Discussion – Q & A

Day2 May 18, Friday

9:00-9:40 Mr. Zhuohan HU, PhD, President & CEO, Research Institute for Liver Diseases (Shanghai) Inc.; Professor, Fudan University & Shanghai University of Chinese Medicines Shanghai, China

Topic: Bridging Discovery to Development in Therapeutic Innovation: Challenges and Solutions

9:40-10:20 Mr. James S. YAN, M.D. PhD, DABT, Senior Director and Site Scientific Lead of Covance Pharmaceutical R&D (Shanghai) Co., Ltd.

Topic: Project Management during Pharmaceutical Preclinical R&D: Study Design, Facilities and Data Interpretation

10:20-10:40 Coffee Break + Exhibition Visit

10:40-11:20 Mr. Yi YANG, PhD, RVT, Director of Preclinical Safety, DPE in Preclinical Safety of DSAR Asia-Pacific Sanofi-aventis China

Topic: Special Considerations in Preclinical Safety Assessment to Support Biopharmaceutical Development

11:20-12:00 Mr. Dylan Dalin YAO, MD, PhD, Senior VP & Chief Scientific Officer of Joinn Laboratories Inc.

Topic: Dual Solutions for Filing Nonclinical Pharm/Tox Data in Regulatory Submissions to Both the Domestic and International Agencies

12:00-13:30 Luncheon

13:30-14:10 Ms. Wen CAO, M.D, PhD, Manager of Phase I Clinical Trail in VPS Clinical Group.

Topic: Early Clinical Research on Drug Innovation

14:10-14:50 Mr. Ming GUO, PhD, Co-Founder & COO of Ascentage Pharma; General Manager of Small Molecule Drug R&D Center, China Medical City

Topic: An Experienced Partner in Late Discovery and IND Enabling at China Medical City

14:50-15:10 Coffee Break + Exhibition Visit

15:10-15:50 Mr. Zhenyu XUAN, PhD,General Manager of Suzhou Youseen New Drug R&D Co. Ltd., Senior Engineer; Professor of Shanghai University of TCM; Shanghai excellent academic leader

Topic: CRO Service for Traditional Chinese Medicine Development and the Entrance of TCM into Global Market

15:50-16:30 Panel Discussion – Q&A – Conference Conclusion